KYORIN Pharmaceutical Co., Ltd. (KYRNF)
10.31
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
KYORIN Pharmaceutical Total Liabilities (Quarterly) : 333.30M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 48.26B |
| Daiichi Sankyo Co., Ltd. | 14.72B |
| Eisai Co., Ltd. | 3.294B |
| Chugai Pharmaceutical Co., Ltd. | 2.246B |
| Santen Pharmaceutical Co., Ltd. | 798.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.229B |
| Shareholders Equity (Quarterly) | 895.25M |
| Debt to Equity Ratio | 0.167 |
| Current Ratio | 4.602 |
| Net Debt Paydown Yield | 1.95% |